Amgen Faces Suit, Subpoenas Over Alleged Tying

Law360, New York (November 12, 2007, 12:00 AM EST) -- A health fund has filed a proposed class action lawsuit against biotech company Amgen Inc., alleging it is illegally tying and pricing the sales of three of its oncology products.

The lawsuit, filed Nov. 2 in the U.S. District Court for the District of New Jersey, was announced on Friday by Amgen in a filing with the U.S. Securities and Exchange Commission. The California-based company also disclosed that it had been subpoenaed by the U.S. Attorney's Offices of the Eastern District of New York and the...
To view the full article, register now.